Demographic characteristics, thromboembolism risk, and treatment patterns for patients with cold agglutinin disease in Japan
- 30 June 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in International Journal of Hematology
- Vol. 112 (3), 307-315
- https://doi.org/10.1007/s12185-020-02899-6
Abstract
Cold agglutinin disease (CAD) is a rare, complement-mediated autoimmune hemolytic anemia. Patients with CAD in the United States and Europe have an increased incidence of thromboembolism (TE), but comparable information for patients in other regions is lacking. Thus, we examined TE risk for patients with CAD in Japan. Patients with CAD (at least three claims with a CAD diagnosis; Japanese Disease Code 2830009) and non-CAD controls were retrospectively identified (2008–2017) from a large hospital-based administrative claims dataset in Japan. Cohorts were compared using conditional logistic regression. We identified 344 patients with CAD (53.2% female; mean age: 66.8 years) and 3440 matched controls. Patients with CAD had higher TE rates than controls (34.9% vs. 17.9%; P < 0.0001). Both arterial and venous TEs were increased in the CAD group when compared with the control group (25.0% vs. 4.6% and 8.4% vs. 4.0%, respectively; both P < 0.0001). Most arterial TEs in the CAD cohort (87.2%) were myocardial infarctions. The overall odds ratio for TE development in CAD was 2.81 (95% confidence interval 2.18–3.61). CAD in Japan is characterized by an increased risk of TE. The rate of arterial TEs was particularly high in this patient population.Keywords
Funding Information
- Sanofi
This publication has 39 references indexed in Scilit:
- Epidemiology and Registry Studies of Stroke in JapanJournal of Stroke, 2013
- Complement in atherosclerosis: friend or foe?Journal of Thrombosis and Haemostasis, 2011
- Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria: the AEGIS Clinical TrialInternational Journal of Hematology, 2011
- Role of Extracellular Hemoglobin in Thrombosis and Vascular Occlusion in Patients with Sickle Cell AnemiaAnemia, 2010
- Local complement activation triggers neutrophil recruitment to the site of thrombus formation in acute myocardial infarctionThrombosis and Haemostasis, 2009
- The role of complement in atherosclerosisCurrent Opinion in Lipidology, 2008
- Elevated levels of circulating procoagulant microparticles in patients with -thalassemia intermediaHaematologica, 2008
- Complement and coagulation: strangers or partners in crime?Trends in Immunology, 2007
- Complement component C5a predicts future cardiovascular events in patients with advanced atherosclerosisEuropean Heart Journal, 2005
- Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patientsBlood, 2004